Growth-differentiation factor-15 in cardiovascular disease

Basic Research in Cardiology

Volumn 102, Issue 5, 2007, Pages 412-415

  Wollert, Kai C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GROWTH DIFFERENTIATION FACTOR 15; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DEATH; EDITORIAL; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN BLOOD LEVEL; UPREGULATION; WOUND HEALING;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CYTOKINES; HUMANS; PROGNOSIS;

EID: 34548042300     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-007-0662-3     Document Type: Editorial

References (13)

1. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H,Wollert KC (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/ reperfusion injury. Circ Res 98:351-360
2. Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ (2000) Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 20:3742-3751
3. 2-induced apoptosis. Physiol Genomics 29:118-127
4. Buitrago M, Lorenz K,Maass AH,Oberdorf- Maass S, Keller U, Schmitteckert EM, Ivashchenko Y, Lohse MJ, Engelhardt S (2005) The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 11:837-844
5. Xu J,Kimball TR,Lorenz JN,Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD (2006) GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 98:342-350
6. Bootcov MR, Bauskin AR, Valenzuela SM,Moore AG, Bansal M,He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ,Nicholson RC,Fairlie WD,Por SB, Robbins JM, Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94:11514-11519
7. Bottner M, Suter-Crazzolara C, Schober A, Unsicker K (1999) Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor- 15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297:103-110
8. Schober A, Bottner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Schilling L, Fairlie WD, Breit SN, Unsicker K (2001) Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol 439:32-45
9. Schulz R, Kelm M,Heusch G (2004) Nitric oxide in myocardial ischemia/ reperfusion injury. Cardiovasc Res 61:402-413
10. Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T,Klein G, Drexler H, Johnston N, Wallentin L, Wollert KC (2007) Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 53:284-291
11. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N,Lindahl B,Horn- Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-segment elevation acute coronary syndrome. Circulation 115:962-971
12. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC (2007) Prognostic utility of growth-differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol (in press)
13. de Lemos JA,McGuire DK,Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322